Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-38062745

ABSTRACT

Objective: Electrical Stimulation Therapy (EST) shows promise for the purpose of accelerating wound healing, but the right electrical stimulation parameters and its mode of action remain unclear. We aim to evaluate the effect of a new EST clinical device on epidermal repair using an in vitro human skin wound model. Approach: We scaled up a well-established 3D De-Epidermized Dermis-Human Skin Equivalent (DED-HSE) wound model to fit a clinically used device that delivers preprogrammed microcurrent EST. The impact of EST on re-epithelialization of 4-mm circular epidermal wounds was assessed after 4 and 7 days of treatment, using metabolic activity assay, immunohistochemistry (IHC) staining, and RNA in situ hybridization. Results: EST was successfully applied to the wounded in vitro skin model. Large DED-HSEs retained good cell viability for up to 7 days of EST treatment. Excisional wounds subjected to EST for 4 days consistently exhibited faster closure (mean 65.8%, n = 9) compared to untreated wounds (mean 49.7%, n = 9) (p < 0.05). Wounds exposed to EST exhibited significantly longer epithelial tongues (re-epithelialization mean 50.3%, n = 9) than untreated wounds (mean 26.2%, n = 9) (p < 0.001), suggesting faster keratinocyte migration and proliferation. Increased MMP1 transcription (p < 0.05) in ES-treated periwound suggests a mechanism for enhanced keratinocyte migration. IHC staining showed advanced epidermal proliferation (p63) and differentiation (K10) in EST-exposed wounds (n = 15), as well as stronger attachment of the newly formed epidermis into the dermis compared to untreated controls (n = 15) (p < 0.001). Innovation: We present a novel approach to assess an EST clinical device designed to stimulate wound healing. Using a scaled-up 3D human skin wound model, we could demonstrate the positive effect of EST on epithelial cell responses and shed light on possible mechanism. Conclusion: Our study provides experimental evidence that microcurrent therapy accelerates wound closure and improves the quantity and quality of re-epithelialization.

2.
Int J Mol Sci ; 22(16)2021 Aug 10.
Article in English | MEDLINE | ID: mdl-34445299

ABSTRACT

Deep partial-thickness burns damage most of the dermis and can cause severe pain, scarring, and mortality if left untreated. This study serves to evaluate the effectiveness of crosslinked keratin-alginate composite sponges as dermal substitutes for deep partial-thickness burns. Crosslinked keratin-alginate sponges were tested for the ability to support human dermal fibroblasts in vitro and to support the closure and healing of partial-thickness burn wounds in Sus scrofa pigs. Keratin-alginate composite sponges supported the enhanced proliferation of human dermal fibroblasts compared to alginate-only sponges and exhibited decreased contraction in vitro when compared to keratin only sponges. As dermal substitutes in vivo, the sponges supported the expression of keratin 14, alpha-smooth muscle actin, and collagen IV within wound sites, comparable to collagen sponges. Keratin-alginate composite sponges supported the regeneration of basement membranes in the wounds more than in collagen-treated wounds and non-grafted controls, suggesting the subsequent development of pathological scar tissues may be minimized. Results from this study indicate that crosslinked keratin-alginate sponges are suitable alternative dermal substitutes for clinical applications in wound healing and skin regeneration.


Subject(s)
Alginates/therapeutic use , Burns/therapy , Keratins/therapeutic use , Wound Healing , Alginates/chemistry , Alginates/pharmacology , Animals , Bandages, Hydrocolloid , Burns/pathology , Burns/physiopathology , Cells, Cultured , Dermis/drug effects , Dermis/pathology , Dermis/physiopathology , Humans , Hydrogels/chemistry , Hydrogels/therapeutic use , Keratins/chemistry , Keratins/pharmacology , Male , Materials Testing , Severity of Illness Index , Skin/drug effects , Skin/pathology , Skin/physiopathology , Swine , Wound Healing/drug effects , Wound Healing/physiology
3.
Pediatr Dermatol ; 38(4): 908-912, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34152038

ABSTRACT

We report a case of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) with minimal skin involvement but severe protein-losing enteropathy and airway involvement. Genetic analysis revealed heterozygous mutations in the ITGB4 gene encoding integrin ß4 protein. Parental testing confirmed inheritance of frameshift variant (c.794dupC) as maternal and splice site variant (c.1608C>T/p.Cys536Cys) as paternal. Immunofluorescence mapping of her skin revealed a subepidermal blister with decreased and frayed integrin ß4 at both the floor and the roof of the blister, while the intestinal mucosa showed complete absence of integrin ß4. We review the literature and discuss the differential expression of integrins in the skin and gastrointestinal tract, as well as the role of chronic inflammation in the pathogenesis of EB.


Subject(s)
Ectodermal Dysplasia , Epidermolysis Bullosa , Epidermolysis Bullosa/diagnosis , Epidermolysis Bullosa/genetics , Female , Humans , Integrin beta4/genetics , Mutation , Pylorus
4.
Am J Med Genet A ; 185(2): 625-630, 2021 02.
Article in English | MEDLINE | ID: mdl-33258232

ABSTRACT

Self-improving dystrophic epidermolysis bullosa is a rare subtype of dystrophic epidermolysis bullosa (DEB) characterized by significant improvement in skin fragility within the first few years of life. Genetic inheritance has previously been reported as autosomal dominant or recessive with both forms harboring mutations in COL7A1. To date, there have been no reports of this rare clinical entity from various Southeast Asian ethnicities. Here, we describe the clinical and molecular features of five patients from the Southeast Asia region who presented with predominantly acral-distributed blisters and erosions in the first few days of life. Blistering resolved over several months, without appearance of new blisters. By immunofluorescence, intraepidermal retention of Type VII collagen was observed in all patient skin biopsies when investigated with antibody staining. Genetic analysis of four patients revealed pathogenic variants in COL7A1 which have not been previously reported. The clinical diagnosis in these rare patients is confirmed with molecular histology and genetic characterization.


Subject(s)
Collagen Type VII/genetics , Epidermolysis Bullosa Dystrophica/genetics , Genetic Predisposition to Disease , Skin Abnormalities/genetics , Asia, Southeastern/epidemiology , Biopsy , Child, Preschool , Epidermolysis Bullosa Dystrophica/diagnosis , Epidermolysis Bullosa Dystrophica/physiopathology , Epidermolysis Bullosa Dystrophica/therapy , Female , Humans , Infant , Infant, Newborn , Male , Skin Abnormalities/diagnosis , Skin Abnormalities/physiopathology , Skin Abnormalities/therapy
6.
PeerJ ; 4: e2377, 2016.
Article in English | MEDLINE | ID: mdl-27635341

ABSTRACT

Asian seabass (Lates calcarifer) is a food fish of increasing aquaculture importance. In order to improve our understanding on the digestive system and feeding of this species, morphological and histological features of the gut were studied. Morphologically, the Asian seabass gut is defined by a short and muscular esophagus, well-developed stomach and comparatively short intestine. Mucous secreting goblet cells reactive to PAS (Periodic Acid Schiff) and AB (Alcian Blue) stain were present throughout the esophagus. The stomach was sac-like and could be distinguished into the cardiac, fundic and pyloric regions. Gastric glands and mucus cells were predominately present in the cardiac and fundic regions. Five finger-like pyloric caeca were present between the stomach and intestine. The intestine was a short, tubular structure with no morphological differences between the various regions. Histologically, the intestinal regions were similar, the main difference being in the number of goblet cells that increased from anterior to posterior intestine, with 114 ± 9, 153 ± 7 and 317 ± 21 goblet cells in the anterior, mid and posterior regions, respectively. The intestinal epithelium stained positively for PAS, but the staining was stronger for acidic glycoproteins. The rectum was similar to intestine, except for increased goblet cell numbers (anterior rectum: 529 ± 26; posterior rectum: 745 ± 29). Gut morpho-histology did not respond to salinity changes, however, there was a significant reduction of mucosal height, goblet cell numbers and muscularis thickness upon food deprivation.

7.
Nat Commun ; 7: 11702, 2016 06 21.
Article in English | MEDLINE | ID: mdl-27325363

ABSTRACT

The tumour-initiating cell (TIC) model accounts for phenotypic and functional heterogeneity among tumour cells. MicroRNAs (miRNAs) are regulatory molecules frequently aberrantly expressed in cancers, and may contribute towards tumour heterogeneity and TIC behaviour. More recent efforts have focused on miRNAs as diagnostic or therapeutic targets. Here, we identified the TIC-specific miRNAs, miR-1246 and miR-1290, as crucial drivers for tumour initiation and cancer progression in human non-small cell lung cancer. The loss of either miRNA impacted the tumour-initiating potential of TICs and their ability to metastasize. Longitudinal analyses of serum miR-1246 and miR-1290 levels across time correlate their circulating levels to the clinical response of lung cancer patients who were receiving ongoing anti-neoplastic therapies. Functionally, direct inhibition of either miRNA with locked nucleic acid administered systemically, can arrest the growth of established patient-derived xenograft tumours, thus indicating that these miRNAs are clinically useful as biomarkers for tracking disease progression and as therapeutic targets.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Carcinoma, Non-Small-Cell Lung/genetics , Gene Expression Regulation, Neoplastic , Lung Neoplasms/genetics , MicroRNAs/antagonists & inhibitors , Oligonucleotides/genetics , A549 Cells , Animals , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/therapy , Disease Progression , Female , Gefitinib , HEK293 Cells , Humans , Hydroxychloroquine/pharmacology , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Lung Neoplasms/therapy , Lymphatic Metastasis , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Oligonucleotides/administration & dosage , Oligonucleotides/metabolism , Quinazolines/pharmacology , Signal Transduction , Survival Analysis , Tumor Burden , Xenograft Model Antitumor Assays
8.
J Invest Dermatol ; 134(3): 754-763, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23962810

ABSTRACT

Keratin 9 (K9) is a type I intermediate filament protein whose expression is confined to the suprabasal layers of the palmoplantar epidermis. Although mutations in the K9 gene are known to cause epidermolytic palmoplantar keratoderma, a rare dominant-negative skin disorder, its functional significance is poorly understood. To gain insight into the physical requirement and importance of K9, we generated K9-deficient (Krt9(-/-)) mice. Here, we report that adult Krt9(-/-)mice develop calluses marked by hyperpigmentation that are exclusively localized to the stress-bearing footpads. Histological, immunohistochemical, and immunoblot analyses of these regions revealed hyperproliferation, impaired terminal differentiation, and abnormal expression of keratins K5, K14, and K2. Furthermore, the absence of K9 induces the stress-activated keratins K6 and K16. Importantly, mice heterozygous for the K9-null allele (Krt9(+/-)) show neither an overt nor histological phenotype, demonstrating that one Krt9 allele is sufficient for the developing normal palmoplantar epidermis. Together, our data demonstrate that complete ablation of K9 is not tolerable in vivo and that K9 is required for terminal differentiation and maintaining the mechanical integrity of palmoplantar epidermis.


Subject(s)
Epidermis/physiology , Keratin-9/genetics , Keratin-9/physiology , Keratoderma, Palmoplantar, Epidermolytic/genetics , Age Factors , Animals , Cell Differentiation/physiology , Cell Proliferation , Cytoskeleton/pathology , Disease Models, Animal , Epidermis/pathology , Hyperpigmentation/genetics , Hyperpigmentation/pathology , Keratoderma, Palmoplantar, Epidermolytic/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Phenotype , RNA, Small Interfering/genetics
9.
PLoS One ; 8(5): e64404, 2013.
Article in English | MEDLINE | ID: mdl-23741325

ABSTRACT

Keratin 7 (K7) is a Type II member of the keratin superfamily and despite its widespread expression in different types of simple and transitional epithelia, its functional role in vivo remains elusive, in part due to the lack of any appropriate mouse models or any human diseases that are associated with KRT7 gene mutations. Using conventional gene targeting in mouse embryonic stem cells, we report here the generation and characterisation of the first K7 knockout mouse. Loss of K7 led to increased proliferation of the bladder urothelium although this was not associated with hyperplasia. K18, a presumptive type I assembly partner for K7, showed reduced expression in the bladder whereas K20, a marker of the terminally differentiated superficial urothelial cells was transcriptionally up-regulated. No other epithelia were seen to be adversely affected by the loss of K7 and western blot and immunofluorescence microscopy analysis revealed that the expression of K8, K18, K19 and K20 were not altered in the absence of K7, with the exception of the kidney where there was reduced K18 expression.


Subject(s)
Founder Effect , Keratin-7/genetics , Mice, Knockout/genetics , Urinary Bladder/metabolism , Urothelium/metabolism , Animals , Cell Proliferation , Female , Gene Expression Regulation , Keratin-18/genetics , Keratin-18/metabolism , Keratin-19/genetics , Keratin-19/metabolism , Keratin-20/genetics , Keratin-20/metabolism , Keratin-7/deficiency , Keratin-8/genetics , Keratin-8/metabolism , Male , Mice , Mice, Knockout/metabolism , Protein Binding , Urinary Bladder/cytology , Urothelium/cytology
10.
J Cell Biol ; 200(5): 605-17, 2013 Mar 04.
Article in English | MEDLINE | ID: mdl-23439683

ABSTRACT

The nuclear lamina consists of A- and B-type lamins. Mutations in LMNA cause many human diseases, including progeria, a premature aging syndrome, whereas LMNB1 duplication causes adult-onset autosomal dominant leukodystrophy (ADLD). LMNB1 is reduced in cells from progeria patients, but the significance of this reduction is unclear. In this paper, we show that LMNB1 protein levels decline in senescent human dermal fibroblasts and keratinocytes, mediated by reduced transcription and inhibition of LMNB1 messenger ribonucleic acid (RNA) translation by miRNA-23a. This reduction is also observed in chronologically aged human skin tissue. To determine whether altered LMNB1 levels cause senescence, we either increased or reduced LMNB1. Both LMNB1 depletion and overexpression inhibited proliferation, but only LMNB1 overexpression induced senescence, which was prevented by telomerase expression or inactivation of p53. This phenotype was exacerbated by a simultaneous reduction of LMNA/C. Our results demonstrate that altering LMNB1 levels inhibits proliferation and are relevant to understanding the molecular pathology of ADLD.


Subject(s)
Cell Proliferation , Cellular Senescence , Fibroblasts/metabolism , Keratinocytes/metabolism , Lamin Type B/metabolism , Cell Differentiation , Cells, Cultured , DNA Damage , DNA-Binding Proteins/metabolism , Down-Regulation , Fibroblasts/pathology , Genotype , Humans , Keratinocytes/pathology , Lamin Type A/metabolism , Lamin Type B/genetics , Membrane Proteins/metabolism , MicroRNAs/metabolism , Nuclear Lamina/metabolism , Pelizaeus-Merzbacher Disease/genetics , Pelizaeus-Merzbacher Disease/metabolism , Pelizaeus-Merzbacher Disease/pathology , Phenotype , RNA Interference , RNA, Messenger/metabolism , Skin Aging , Telomerase/metabolism , Time Factors , Transcription, Genetic , Transfection , Tumor Suppressor Protein p53/metabolism , Up-Regulation
11.
Nature ; 495(7439): 103-6, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-23395958

ABSTRACT

Post-transcriptional switches are flexible effectors of dynamic changes in gene expression. Here we report a new post-transcriptional switch that dictates the spatiotemporal and mutually exclusive expression of two alternative gene products from a single transcript. Expression of primate-specific exonic microRNA-198 (miR-198), located in the 3'-untranslated region of follistatin-like 1 (FSTL1) messenger RNA, switches to expression of the linked open reading frame of FSTL1 upon wounding in a human ex vivo organ culture system. We show that binding of a KH-type splicing regulatory protein (KSRP, also known as KHSRP) to the primary transcript determines the fate of the transcript and is essential for the processing of miR-198: transforming growth factor-ß signalling switches off miR-198 expression by downregulating KSRP, and promotes FSTL1 protein expression. We also show that FSTL1 expression promotes keratinocyte migration, whereas miR-198 expression has the opposite effect by targeting and inhibiting DIAPH1, PLAU and LAMC2. A clear inverse correlation between the expression pattern of FSTL1 (pro-migratory) and miR-198 (anti-migratory) highlights the importance of this regulatory switch in controlling context-specific gene expression to orchestrate wound re-epithelialization. The deleterious effect of failure of this switch is apparent in non-healing chronic diabetic ulcers, in which expression of miR-198 persists, FSTL1 is absent, and keratinocyte migration, re-epithelialization and wound healing all fail to occur.


Subject(s)
Follistatin-Related Proteins/genetics , Gene Expression Regulation/genetics , MicroRNAs/genetics , RNA, Messenger/genetics , Transcription, Genetic/genetics , Wound Healing/genetics , Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Adaptor Proteins, Signal Transducing/metabolism , Cell Movement , Diabetic Foot/genetics , Diabetic Foot/metabolism , Diabetic Foot/pathology , Exons/genetics , Follistatin-Related Proteins/biosynthesis , Formins , Humans , In Vitro Techniques , Keratinocytes/cytology , Keratinocytes/metabolism , Laminin/antagonists & inhibitors , Laminin/metabolism , Open Reading Frames/genetics , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Skin/cytology , Skin/injuries , Skin/metabolism , Skin/pathology , Time Factors , Trans-Activators/genetics , Trans-Activators/metabolism , Transforming Growth Factor beta1/metabolism , Urokinase-Type Plasminogen Activator/antagonists & inhibitors , Urokinase-Type Plasminogen Activator/metabolism
12.
Nat Genet ; 43(4): 365-9, 2011 Feb 27.
Article in English | MEDLINE | ID: mdl-21358634

ABSTRACT

Multiple self-healing squamous epithelioma (MSSE), also known as Ferguson-Smith disease (FSD), is an autosomal-dominant skin cancer condition characterized by multiple squamous-carcinoma-like locally invasive skin tumors that grow rapidly for a few weeks before spontaneously regressing, leaving scars. High-throughput genomic sequencing of a conservative estimate (24.2 Mb) of the disease locus on chromosome 9 using exon array capture identified independent mutations in TGFBR1 in three unrelated families. Subsequent dideoxy sequencing of TGFBR1 identified 11 distinct monoallelic mutations in 18 affected families, firmly establishing TGFBR1 as the causative gene. The nature of the sequence variants, which include mutations in the extracellular ligand-binding domain and a series of truncating mutations in the kinase domain, indicates a clear genotype-phenotype correlation between loss-of-function TGFBR1 mutations and MSSE. This distinguishes MSSE from the Marfan syndrome-related disorders in which missense mutations in TGFBR1 lead to developmental defects with vascular involvement but no reported predisposition to cancer.


Subject(s)
Mutation , Protein Serine-Threonine Kinases/genetics , Receptors, Transforming Growth Factor beta/genetics , Skin Neoplasms/genetics , Amino Acid Sequence , Base Sequence , Carcinoma/genetics , Carcinoma/metabolism , Codon, Nonsense , Conserved Sequence , DNA Primers/genetics , Female , Frameshift Mutation , Genetic Association Studies , Haplotypes , Humans , Keratoacanthoma/genetics , Keratoacanthoma/metabolism , Male , Marfan Syndrome/genetics , Models, Molecular , Molecular Sequence Data , Mutant Proteins/chemistry , Mutant Proteins/genetics , Mutant Proteins/metabolism , Mutation, Missense , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/metabolism , Protein Structure, Tertiary , Receptor, Transforming Growth Factor-beta Type I , Receptors, Transforming Growth Factor beta/chemistry , Receptors, Transforming Growth Factor beta/metabolism , Sequence Homology, Amino Acid , Skin Neoplasms/metabolism
13.
Anat Rec (Hoboken) ; 293(11): 1864-72, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20818615

ABSTRACT

Although tridermic species have two junctional regions of ectoderm and endoderm between their epidermis and digestive tract, we actually know little about these particular boundaries. Cytokeratins are the major intermediate filaments of epithelial cells and show a high degree of tissue specificity. Therefore, to characterize the epithelial cells in the junctional region of ectoderm and endoderm, we immunohistochemically examined the localization of cytokeratins 5, 7/17, 14, 18, Sox17, and alpha-fetoprotein (AFP) in the oropharyngeal and anorectal regions during the mouse gastrulation process. At embryonic day (E) 9.5, cytokeratins 5, 7/17, 14, and 18 were detected in all epithelial cells of the oropharyngeal region. At E12.5, cytokeratin 5-positive cells were not observed in the middle area of the oral cavity; however, the immunoreactivity was strong in the anterior and posterior areas. The immunoreaction of cytokeratins 18 was seen only in the middle and posterior areas of the oral mucosa. Cytokeratins 7/17 and 14 were localized in all areas of the oropharyngeal region. Sox17 and AFP, which are endodermal markers, were detected in the middle and posterior areas of the oral mucosa, but not in the anterior area. Moreover, this same localization pattern of cytokeratins also existed in the anorectal region of the E12.5 embryo, suggesting that the localization of cytokeratins and endodermal markers might give an implication for the boundary between ectoderm and endoderm. These results also suggest that these cytokeratins are useful molecules for monitoring the epithelial cell differentiation in the junctional region of the germ layers.


Subject(s)
Ectoderm/metabolism , Embryo, Mammalian/metabolism , Endoderm/metabolism , Epithelial Cells/metabolism , Gastrulation , Intercellular Junctions/metabolism , Keratins/metabolism , Anal Canal/cytology , Anal Canal/metabolism , Animals , Biomarkers , Cell Differentiation , Ectoderm/cytology , Embryo, Mammalian/cytology , Endoderm/cytology , Epithelial Cells/cytology , Female , Keratin-14/metabolism , Keratin-18/metabolism , Keratin-5/metabolism , Keratin-7/metabolism , Mice , Oropharynx/cytology , Oropharynx/metabolism , Pregnancy , Rectum/cytology , Rectum/metabolism
14.
Cancer Res ; 70(13): 5316-25, 2010 Jul 01.
Article in English | MEDLINE | ID: mdl-20530671

ABSTRACT

The viral E2 gene product plays a crucial role in the human papillomavirus (HPV) vegetative cycle by regulating both transcription and replication of the viral genome. E2 is a transcriptional repressor of the E6 and E7 viral oncogenes for HPV types 16 and 18, which are involved in cervical cancers. Using new polyclonal antibodies against the HPV16 E2 protein, we showed that E2 is expressed at various precursor stages of cervical carcinoma by immunohistochemistry on paraffin-embedded clinical samples. E2 was found to be highly expressed in the nuclei and cytoplasm of cells forming the intermediate and upper layers of cervical intraepithelial neoplasia (CIN). We could show that the expressions of E2 and p16(INK4a) (surrogate marker for oncogenic E7 expression) were exclusive in most of the cases, thus implying that E2 is not expressed together with high levels of E7. Moreover, we found that E2 is expressed in a subset of columnar cells adjacent to the CIN. We could show that expression of E2 is topologically distinct from the proliferation markers p63 and Ki67, whereas it coincides with the expression of cytokeratin K13, a marker of squamous cell differentiation. Expression of E2 also topologically coincides with episomal amplification of viral genomes in the upper layers of CIN1. These in vivo data thus validate previous assumptions of the crucial role of E2 in the early steps of HPV infection and of its negative link with expression of the viral E6 and E7 oncogenes.


Subject(s)
Biomarkers, Tumor/analysis , DNA-Binding Proteins/analysis , Human papillomavirus 16/metabolism , Oncogene Proteins, Viral/analysis , Papillomavirus E7 Proteins/analysis , Papillomavirus Infections/virology , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/virology , Antibodies/chemistry , Antibody Specificity , DNA Replication , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/immunology , Female , Human papillomavirus 16/genetics , Human papillomavirus 16/isolation & purification , Humans , Immunohistochemistry , Oncogene Proteins, Viral/biosynthesis , Oncogene Proteins, Viral/immunology , Papillomavirus E7 Proteins/biosynthesis , Papillomavirus E7 Proteins/immunology , Papillomavirus Infections/diagnosis , Paraffin Embedding , Uterine Cervical Neoplasms/diagnosis , Virus Replication , Uterine Cervical Dysplasia/diagnosis
15.
Hum Mutat ; 29(3): 351-60, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18033728

ABSTRACT

We describe a revised and expanded database on human intermediate filament proteins, a major component of the eukaryotic cytoskeleton. The family of 70 intermediate filament genes (including those encoding keratins, desmins, and lamins) is now known to be associated with a wide range of diverse diseases, at least 72 distinct human pathologies, including skin blistering, muscular dystrophy, cardiomyopathy, premature aging syndromes, neurodegenerative disorders, and cataract. To date, the database catalogs 1,274 manually-curated pathogenic sequence variants and 170 allelic variants in intermediate filament genes from over 459 peer-reviewed research articles. Unrelated cases were collected from all of the six sequence homology groups and the sequence variations were described at cDNA and protein levels with links to the related diseases and reference articles. The mutations and polymorphisms are presented in parallel with data on protein structure, gene, and chromosomal location and basic information on associated diseases. Detailed statistics relating to the variants records in the database are displayed by homology group, mutation type, affected domain, associated diseases, and nucleic and amino acid substitutions. Multiple sequence alignment algorithms can be run from queries to determine DNA or protein sequence conservation. Literature sources can be interrogated within the database and external links are provided to public databases. The database is freely and publicly accessible online at www.interfil.org (last accessed 13 September 2007). Users can query the database by various keywords and the search results can be downloaded. It is anticipated that the Human Intermediate Filament Database (HIFD) will provide a useful resource to study human genome variations for basic scientists, clinicians, and students alike.


Subject(s)
Databases, Genetic , Intermediate Filament Proteins/genetics , Multigene Family , Algorithms , Amino Acid Sequence , Base Sequence , Chromosome Mapping , DNA, Complementary/genetics , Humans , Molecular Sequence Data , Mutation , Polymorphism, Genetic , Sequence Alignment/statistics & numerical data , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
16.
Cell Tissue Res ; 325(2): 253-61, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16552524

ABSTRACT

The development of gustatory papillae in mammalian embryos requires the coordination of a series of morphological events, such as proliferation, differentiation and innervation. In mice, the circumvallate papilla (CVP) is a specialized structure that develops in a characteristic spatial and temporal pattern in the posterior region of the tongue dorsal surface. The distinct expression patterns of Shh and Ptc, which play important roles in the development of other epithelial appendages, have been localized in the trench wall that gives rise to von Ebner's gland (VEG). To define the cellular mechanisms responsible for morphogenesis and differentiation during early development of CVP and VEG, the localization patterns of keratins (cytokeratins) K7, K8, K18, K19, K14 and connexin-43, which are dependent on Shh expression in other developmental systems, have been examined in detail. The distinct localization of keratins K7, K8, K18, K19, K14 and connexin-43 in the epithelium giving rise to the CVP and VEG suggests that cytodifferentiation is established prior to morphological changes. Interestingly, the localization of proliferating cell nuclear antigen, a marker for cell proliferation, is similar to that of Shh. An understanding of the regulatory roles of cell-cell interactions and signalling molecules in orchestrating a mutual network will bring us nearer to defining the molecular and cellular mechanisms underlying morphogenesis in mammalian taste bud development.


Subject(s)
Hedgehog Proteins/biosynthesis , Keratins/biosynthesis , Receptors, Cell Surface/biosynthesis , Salivary Glands, Minor/metabolism , Taste Buds/metabolism , Tongue/metabolism , Animals , Antigens, Differentiation/biosynthesis , Cell Differentiation , Cell Proliferation , Connexin 43/biosynthesis , Embryo, Mammalian/cytology , Female , Immunohistochemistry , Mice , Mice, Inbred ICR , Morphogenesis , Patched Receptors , Patched-1 Receptor , Proliferating Cell Nuclear Antigen/biosynthesis , Salivary Glands, Minor/cytology , Salivary Glands, Minor/embryology , Signal Transduction , Taste Buds/cytology , Taste Buds/embryology , Tongue/cytology , Tongue/embryology
17.
J Investig Dermatol Symp Proc ; 10(1): 3-17, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16250204

ABSTRACT

Pachyonychia congenita (PC) is a rare genodermatosis affecting the nails, skin, oral mucosae, larynx, hair, and teeth. Pathogenic mutations in keratins K6a or K16 are associated with the PC-1 phenotype whereas K6b and K17 mutations are associated with the PC-2 phenotype. Analysis of clinical, pathological, and genetic data from the literature and two research registries reveal that >97% of PC cases exhibit fingernail and toenail thickening, and painful plantar keratoderma. Prospective evaluation of 57 PC patients from 41 families revealed variable clinical findings: hyperhidrosis (79%), oral leukokeratosis (75%), follicular keratosis (65%), palmar keratoderma (60%), cutaneous cysts (35%), hoarseness or laryngeal involvement (16%), coarse or twisted hair (26%), early primary tooth loss (14%), and presence of natal or prenatal teeth (2%). Stratification of these data by keratin mutation confirmed the increased incidence of cyst formation and natal teeth among PC-2 patients, although cysts were more commonly seen in PC-1 than previously reported (25%-33%). Previously unreported clinical features of PC include development of painful oral and nipple lesions during breastfeeding, copious production of waxy material in ears, and inability to walk without an ambulatory aid (50%). Possible pathogenic mechanisms are discussed with respect to the clinicopathologic and genetic correlations observed.


Subject(s)
Ectodermal Dysplasia/pathology , Keratoderma, Palmoplantar/pathology , Nails, Malformed/pathology , Darier Disease/congenital , Darier Disease/genetics , Darier Disease/pathology , Ectodermal Dysplasia/genetics , Female , Genes, Dominant , Genotype , Humans , Keratins/chemistry , Keratins/genetics , Keratoderma, Palmoplantar/congenital , Keratoderma, Palmoplantar/genetics , Male , Mutation , Nails, Malformed/congenital , Nails, Malformed/genetics , Phenotype
18.
J Invest Dermatol ; 124(3): 615-21, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15737203

ABSTRACT

Defolliculated (Dfl) is a spontaneous mouse mutant with a hair-loss phenotype that includes altered sebaceous gland differentiation, short hair shafts, aberrant catagen stage of the hair cycle, and eventual loss of the hair follicle. Recently a similar mutant, finnegan (Fgn), with an identical phenotype was discovered during a phenotypic screen for mutations induced by chemical mutagenesis. The gene underlying the phenotype of both finnegan and defolliculated has been mapped to chromosome 11 and here we show that both mice harbor mutations in gasdermin 3 (Gsdm3), a gene of unknown function. Gsdm3(Dfl) is a B2 insertion near the 3' splice site of exon 7 and Gsdm3(Fgn) is a point mutation T278P. To investigate the role of the gasdermin gene family an antiserum was raised to a peptide highly homologous to all three mouse gasdermins and human gasdermin. Immunohistochemical analysis revealed that gasdermins are expressed specifically in cells at advanced stages of differentiation in the upper epidermis, the differentiating inner root sheath and hair shaft and in the most mature sebocytes of the sebaceous gland and preputial, meibomium, ceruminous gland, and anal glands. This expression pattern suggests a role for gasdermins in differentiation of the epidermis and its appendages.


Subject(s)
Alopecia/genetics , Alopecia/pathology , Hair Follicle/pathology , Proteins/genetics , Sebaceous Glands/pathology , Alopecia/physiopathology , Animals , Antibodies , Antibody Specificity , Base Sequence , Carcinoma, Squamous Cell , Cell Differentiation , Cell Line, Tumor , Hair Follicle/physiopathology , Humans , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Mutant Strains , Molecular Sequence Data , Phenotype , Proteins/immunology , Proteins/metabolism , Sebaceous Glands/physiopathology , Skin Neoplasms
19.
Biochem Biophys Res Commun ; 297(4): 818-27, 2002 Oct 04.
Article in English | MEDLINE | ID: mdl-12359226

ABSTRACT

Keratins are cytoplasmic intermediate filament proteins expressed by epithelial cells. Keratin 7 (K7) is expressed in a wide range of epithelial structures in humans. We have cloned and fully sequenced the human and mouse K7 genes and mRNAs, and the K7 mRNA from the marsupial Potorous tridactylis, from which the widely used simple epithelial cell lines PtK1 and PtK2 are derived. Percentage identity plots comparing the mouse and human genomic sequences revealed a number of conserved CpG islands associated with the K7 gene. There was considerable conservation of introns between the two species, which may indicate the presence of intronic regulatory elements. Only the most proximal 500bp of the promoter was conserved, although an additional conserved sequence island was found 2-3kb upstream. Protein sequence comparisons between the three species allowed identification of conserved regions of the keratin variable domains that may be candidates for protein-protein interactions and/or regulatory modification. From the mouse sequence, we generated a polyclonal rabbit antibody specific for murine K7. This antibody was used to perform a survey of K7 expression in the mouse. The expression pattern was similar to the reported human distribution, with substantial expression observed in lung, bladder, mesothelium, hair follicle, and ductal structures. We also noted previously unreported expression of K7 in the gastrointestinal tract and filiform papillae of the tongue and specific K7 expression in a range of "hard" epithelial tissues. The distribution of K7 in mouse and availability of genomic sequence from the 129/Sv mouse strain will allow the generation and analysis of transgenic mice expressing mutant forms of K7 and to predict the phenotype of human genetic disorders caused by mutations in this keratin.


Subject(s)
Keratins/genetics , Keratins/metabolism , Amino Acid Sequence , Animals , Cell Line , Cloning, Molecular , Conserved Sequence , Evolution, Molecular , Female , Gene Library , Human Genome Project , Humans , Keratin-7 , Keratins/chemistry , Macropodidae , Male , Mice , Molecular Sequence Data , Organ Specificity , Peptide Fragments/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Species Specificity
20.
J Invest Dermatol ; 119(1): 32-7, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12164921

ABSTRACT

Defolliculated is a novel spontaneous mouse mutation that maps to chromosome 11 close to the type I keratin locus. Histology shows abnormal differentiation of the sebaceous gland, with the sebocytes producing little or no sebum and undergoing abnormal cornification. The hair follicles fail to regress during catagen leading to abnormally long follicles. In contrast the hair shafts are shorter than normal, suggesting altered differentiation or proliferation of matrix cells during anagen. The shafts emerge from the follicle with cornified material still attached. The dermis contains increased numbers of immune cells, including T cells (CD4-positive), macrophages, and mast cells, at all time points examined. Complete elimination of all pelage and tail follicles occurs after two to three hair cycles, apparently by necrosis. Defolliculated may be a useful model for determining further functions of the sebaceous gland, and for understanding the regulation of catagen and hair follicle immunology.


Subject(s)
Alopecia/genetics , Alopecia/pathology , Hair Follicle/abnormalities , Mice, Mutant Strains/abnormalities , Sebaceous Glands/abnormalities , Animals , Cell Differentiation/genetics , Cell Differentiation/immunology , Chromosomes , Epidermis/abnormalities , Epidermis/immunology , Epidermis/pathology , Genes, Dominant , Hair Follicle/immunology , Hair Follicle/pathology , Mice , Mice, Inbred BALB C , Phenotype , Sebaceous Glands/immunology , Sebaceous Glands/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...